CpG-adjuvanted SARS-CoV-2 virus vaccine

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11684669
APP PUB NO 20230038284A1
SERIAL NO

17471904

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described herein are CpG-adjuvanted SARS-CoV-2 vaccines and compositions and methods of producing and administering said vaccines to subjects in need thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DYNAVAX TECHNOLOGIES CORPORATION2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Campbell, John Emeryville, US 169 3704
Heindl-Wruss, Jürgen Vienna, AT 25 87
Janssen, Robert S Emeryville, US 12 26
Möhlen, Michael Vienna, AT 9 10
Meinke, Andreas Pressbaum, AT 70 474
Novack, David Emeryville, US 8 7
Reinisch, Christoph Siegenfeld, AT 11 47
Schlegl, Robert Siegenfeld, AT 44 228
Taucher, Christian Vienna, AT 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Dec 27, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 27, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 27, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00